C34 - Multiple Sclerosis in the Trenches: Controversy and Consensus in Clinical Decision-Making

Event Time: Sunday April 22, 2018 7:00 am to 9:00 am
Topic(s): MS and CNS Inflammatory Disease
Director(s): Aaron Miller MD, FAAN
Description: Clinical decision-making in MS has become increasingly complex with more than a dozen disease-modifying agents FDA approved, and still others used off-label. Recent changes in diagnostic criteria and phenotype classification increase the challenges. Assimilating and using this new information may be particularly difficult for neurologists who do not have the extensive experience of MS subspecialists. This course will address those challenges by utilizing a novel, interactive format to engage the audience in answering the practical questions that arise in daily clinical practice. The format will consist of a series of brief case vignettes focused on specific and controversial issues involving clinical decision nodes. For each vignette, two MS experts will offer their opinions about the course of action and the moderator will add or elicit further commentary. The audience may express their own views, before and after the experts, using the audience response system.
Completion Message: Participants should better understand and select DMTs in various circumstances; better understand the use of the McDonald Criteria and their limitations, as well as the new phenotypic descriptions used for MS; and better understand a variety of social and other medical situations that impact the management of people with MS.
CME Credits: 2
Core Competencies: Medical Knowledge, Patient Care

Ready to register for the 2018 AAN Annual Meeting?

Register Now

Related Courses